Warma Neil K 4
4 · ProMIS Neurosciences Inc. · Filed Oct 10, 2024
Insider Transaction Report
Form 4
Warma Neil K
DirectorChief Executive Officer
Transactions
- Award
Option (right to buy)
2024-10-08+490,338→ 1,842,739 totalExercise: $1.15Exp: 2034-10-08→ Common Shares (490,338 underlying) - Award
Option (right to buy)
2024-10-08+1,144,122→ 1,352,455 totalExercise: $1.15Exp: 2034-10-08→ Common Shares (1,144,122 underlying)
Footnotes (2)
- [F1]Initial Award is 25% vested upon grant with the remaining shares vesting ratably over thirty-six months
- [F2]Performance Award shall vest 25% on the date that the 10-day VWAP of the Common Shares on the Nasdaq Capital Market exceeds three times the exercise price, $3.45, with the remainder vesting ratably over the following thirty-six months